Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136,597 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
All-trans retinoic acid and arsenic combination therapy benefits low-to-intermediate-risk patients with newly diagnosed acute promyelocytic leukaemia: a long-term follow-up based on multivariate analysis.
Zhu H, Hu J, Li X, Chen L, Zhao H, Zhou W, Wang L, Zhao X, Zhang Y, Chen Y, Sun H, Chen Q, Chen Y, Zhao W, Mi J, Shen Z, Chen Z, Wang Z, Li J, Chen S. Zhu H, et al. Among authors: wang l, wang z. Br J Haematol. 2015 Oct;171(2):277-280. doi: 10.1111/bjh.13375. Epub 2015 Mar 30. Br J Haematol. 2015. PMID: 25824580 Free article. No abstract available.
The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia.
Zhu H, Hu J, Chen L, Zhou W, Li X, Wang L, Zhao X, Zhang Y, Zhao H, Wang A, Chen Y, Sun H, Chen Q, Chen Y, Zhao W, Mi J, Shen Z, Wang Z, Chen Z, Chen S, Li J. Zhu H, et al. Among authors: wang l, wang z, wang a. Blood. 2016 Sep 15;128(11):1525-8. doi: 10.1182/blood-2016-02-699439. Epub 2016 Jul 11. Blood. 2016. PMID: 27402972 Free article. No abstract available.
FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia.
Long J, Jia MY, Fang WY, Chen XJ, Mu LL, Wang ZY, Shen Y, Xiang RF, Wang LN, Wang L, Jiang CH, Jiang JL, Zhang WJ, Sun YD, Chang L, Gao WH, Wang Y, Li JM, Hong DL, Liang AB, Hu J. Long J, et al. Among authors: wang l, wang zy, wang ln, wang y. Blood. 2020 Apr 23;135(17):1472-1483. doi: 10.1182/blood.2019003538. Blood. 2020. PMID: 32315388 Free article.
Optimization of idarubicin and cytarabine induction regimen with homoharringtonine for newly diagnosed acute myeloid leukemia patients based on the peripheral blast clearance rate: A single-arm, phase 2 trial (RJ-AML 2014).
Zhang Y, Li X, Weng X, Shen Y, Chen Y, Zheng Y, Zhao H, You J, Mao Y, Wang L, Wu M, Sheng Y, Wu J, Hu J, Chen Q, Li J. Zhang Y, et al. Among authors: wang l. Am J Hematol. 2022 Jan 1;97(1):43-51. doi: 10.1002/ajh.26386. Epub 2021 Nov 1. Am J Hematol. 2022. PMID: 34687467 Free article. Clinical Trial.
A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment.
Long J, Chen X, Shen Y, Lei Y, Mu L, Wang Z, Xiang R, Gao W, Wang L, Wang L, Jiang J, Zhang W, Lu H, Dong Y, Ding Y, Zhu H, Hong D, Sun YE, Hu J, Liang A. Long J, et al. Among authors: wang l, wang z. Cell Rep Med. 2023 Nov 21;4(11):101286. doi: 10.1016/j.xcrm.2023.101286. Epub 2023 Nov 10. Cell Rep Med. 2023. PMID: 37951217 Free PMC article.
136,597 results
You have reached the last available page of results. Please see the User Guide for more information.